We are live on
!
Find out more
GCM
Graham Capital Management Portfolio holdings
AUM
$4.14B
1-Year Est. Return
17.82%
This Fund
S&P 500
This Quarter
Est. Return
-1.89%
1 Year Est. Return
+17.82%
3 Year Est. Return
+41.13%
5 Year Est. Return
+43.39%
10 Year Est. Return
+274.46%
AUM
$4.26B
AUM Growth
+$794M
(+23%)
Cap. Flow
-$423M
Cap. Flow
% of AUM
-9.93%
Top 10 Holdings %
Top 10 Hldgs %
37%
Holding
1,372
New
442
Increased
250
Reduced
257
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$41.7M |
| 2 |
Broadcom
AVGO
|
+$33.8M |
| 3 |
Meta Platforms (Facebook)
META
|
+$31.4M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$30.9M |
| 5 |
Mastercard
MA
|
+$30.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$25.7M |
| 2 |
Johnson & Johnson
JNJ
|
+$18M |
| 3 |
Boeing
BA
|
+$16.7M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$16.2M |
| 5 |
IBM
IBM
|
+$16.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.04% |
| 2 | Consumer Discretionary | 7.64% |
| 3 | Financials | 6.86% |
| 4 | Industrials | 6.15% |
| 5 | Communication Services | 4.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Douglas Elliman
DOUG
$162M
| $69K | ﹤0.01% |
30,534
-42,946
| -58% | -$98.6K |
|
927
Marqeta
MQ
$1.66B
| $68.9K | ﹤0.01% |
+2,882
| New | +$65.4K |
|
928
Conduent
CNDT
$264M
| $68.5K | ﹤0.01% |
19,684
-24,533
| -55% | -$81.9K |
|
929
Aldeyra Therapeutics
ALDX
$93.5M
| $67.6K | ﹤0.01% |
+10,123
| New | +$75.1K |
|
930
Perimeter Solutions
PRM
$5.77B
| $63.2K | ﹤0.01% |
+13,921
| New | +$77.6K |
|
|
ORGN
931
DELISTED
Origin Materials
ORGN
| $63.2K | ﹤0.01% |
1,646
+1,135
| +222% | +$89.1K |
|
932
Rekor Systems
REKR
$91.7M
| $63.2K | ﹤0.01% |
+22,406
| New | +$68.3K |
|
933
Hyliion Holdings
HYLN
$690M
| $62.9K | ﹤0.01% |
53,303
-11,037
| -17% | -$16.5K |
|
934
Erasca
ERAS
$6.39B
| $61.5K | ﹤0.01% |
31,229
-27,692
| -47% | -$70.9K |
|
|
OLO
935
DELISTED
Olo Inc
OLO
| $60.8K | ﹤0.01% |
+10,029
| New | +$65.5K |
|
|
HBI
936
DELISTED
Hanesbrands
HBI
| $60.7K | ﹤0.01% |
15,338
-258,078
| -94% | -$1.25M |
|
|
MRSN
937
DELISTED
Mersana Therapeutics
MRSN
| $59.5K | ﹤0.01% |
1,873
-1,077
| -37% | -$51.2K |
|
|
SGMO
938
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $57.6K | ﹤0.01% |
96,102
+28,354
| +42% | +$30.4K |
|
|
GPMT
939
Granite Point Mortgage Trust
GPMT
$61.2M
| $56.7K | ﹤0.01% |
11,628
-13,744
| -54% | -$73.8K |
|
940
Fulcrum Therapeutics
FULC
$297M
| $52.6K | ﹤0.01% |
11,845
-20,103
| -63% | -$87.9K |
|
941
Design Therapeutics
DSGN
$876M
| $51.6K | ﹤0.01% |
+21,850
| New | +$102K |
|
942
Fate Therapeutics
FATE
$326M
| $46K | ﹤0.01% |
21,690
-120,711
| -85% | -$400K |
|
943
Solid Power
SLDP
$532M
| $45.3K | ﹤0.01% |
+22,438
| New | +$53.1K |
|
|
OLPX
944
DELISTED
Olaplex Holdings
OLPX
| $44.9K | ﹤0.01% |
+23,031
| New | +$69.3K |
|
945
Emergent Biosolutions
EBS
$248M
| $43K | ﹤0.01% |
+12,651
| New | +$70.1K |
|
946
SmartRent
SMRT
$272M
| $40.9K | ﹤0.01% |
+15,665
| New | +$53.2K |
|
947
BARK
BARK
$101M
| $34.1K | ﹤0.01% |
1,420
-657
| -32% | -$18.3K |
|
948
Rigel Pharmaceuticals
RIGL
$750M
| $32.5K | ﹤0.01% |
3,008
-5,163
| -63% | -$62.1K |
|
|
BHR
949
Braemar Hotels & Resorts
BHR
$142M
| $29.8K | ﹤0.01% |
+10,769
| New | +$33.4K |
|
950
Kopin
KOPN
$791M
| $29.6K | ﹤0.01% |
24,275
+5,741
| +31% | +$9.3K |
|
Similar funds
SP
BOK
ZP
SHCM
AP
BHC
BG
MGP
Graham Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Graham Capital Management held 1,372 positions worth $4.26B, up 23% from $3.46B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Graham Capital Management withdrew a net $423M in Q3 2023, closing 392 positions and reducing 257 holdings. Its most notable exit was Coca-Cola, an estimated $25.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 9.1% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Graham Capital Management opened a new position in Broadcom worth $32.4M.
- Graham Capital Management's largest Q3 2023 buy was Broadcom: 390,000 shares worth $32.4M.
- Graham Capital Management added most to Walmart Inc in Q3 2023, an estimated $41.7M increase.
- Graham Capital Management's biggest Q3 2023 reduction was Boeing, cutting an estimated $16.7M.
- Graham Capital Management fully exited Coca-Cola in Q3 2023, selling an estimated $25.7M.
- Graham Capital Management's ten largest holdings make up 37% of its $4.26B portfolio in Q3 2023.
- Graham Capital Management opened 442 new positions and closed 392 in Q3 2023.
- Graham Capital Management's portfolio value rose 23% quarter-over-quarter to $4.26B.
Based on Graham Capital Management's 13F filing for Q3 2023, filed 22 Nov 2023.